NSF’s Experimental Program to Stimulate Competitive Research (NSF EPSCoR) has announced a new opportunity for early career faculty – the EPSCoR Research Fellows.
This opportunity is the fourth track within the Research Infrastructure Improvement (RII) program. The RII Track-4 provides opportunities for non-tenured faculty investigators to further develop their individual research potential through extended collaborative visits to the nation’s premier private, governmental, or academic research centers. Through these visits, the EPSCoR Research Fellows will be able to learn new techniques, benefit from access to unique equipment and facilities, and shift their research toward transformative new directions. The experience gained through the fellowship is intended to provide a foundation for research collaborations that span the recipient’s entire career. These benefits to the Fellows are also expected to in turn enhance the research capacity of their institutions and jurisdictions.
Full details for RII Track-4 are available in the solicitation, NSF 17-509. Proposals are due February 28, 2017.CLICK HERE
Project Investigators (PI’s) for all RII Track-4 proposals must hold a non-tenured faculty appointment or its close equivalent, either in the form of a pre-tenure tenure-track position or a long-term non-tenure-track position. There is a limit of three proposal submissions per eligible institution. This means that it is up to the institutions to chose the individuals that will submit proposals, the SD EPSCoR office will not be running a down select (i.e., this program will be competed in the manner that the RII Track-2 proposals are).
Informational webinars for RII Track-4 are planned 2:00 PM Eastern Standard Time on November 29, 2016 and November 30, 2016. Research administrators and potential PIs at EPSCoR-eligible institutions are encouraged to participate on one of these webinars. Further details for webinar participation will follow soon.
Questions regarding the new EPSCoR Research Fellows solicitation/program may be directed to Dr. Timothy VanReken (email@example.com; 703-292-7378).